Tarsus Pharmaceuticals, Inc. TARS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-16
Chart by TradingView
4/9
Piotroski F — financial health
2.84
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $451.4M | $183.0M | $17.4M | $25.8M | $57.0M |
| Operating income | -$71.0M | -$120.6M | -$143.2M | -$62.7M | -$12.2M |
| Net income | -$66.4M | -$115.6M | -$135.9M | -$62.1M | -$13.8M |
| Operating cash flow | -$12.5M | -$83.0M | -$117.5M | -$49.0M | $3.7M |
| Free cash flow | -$22.3M | -$84.6M | -$119.0M | -$49.5M | $3.2M |
| Total assets | $562.2M | $377.0M | $265.5M | $227.9M | $178.9M |
| Total liabilities | $218.7M | $152.5M | $68.5M | $35.0M | $12.2M |
| Shareholders' equity | $343.4M | $224.5M | $197.0M | $192.9M | $166.7M |
| Ratios | |||||
| Operating margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% |
| Net margin | -14.7% | -63.2% | -778.9% | -240.5% | -24.2% |
| FCF margin | -4.9% | -46.2% | -682.0% | -191.9% | 5.5% |
| Return on assets | -11.8% | -30.7% | -51.2% | -27.2% | -7.7% |
| Return on equity | -19.3% | -51.5% | -69.0% | -32.2% | -8.3% |
| Debt / equity | 0.21× | 0.32× | 0.15× | 0.10× | 0.00× |
| Current ratio | 3.85 | 4.42 | 6.93 | 14.61 | 15.33 |
| Revenue growth | 146.7% | 948.6% | -32.4% | -54.7% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 226,251 | $15.9M |
| RENAISSANCE TECHNOLOGIES LLC | 73,400 | $5.1M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.84 (safe)
- Working capital / assets 0.689
- Retained earnings / assets -0.759
- EBIT / assets -0.126
- Equity / liabilities 1.57
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001819790 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.